Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice

Victor V. Lima, Saiprasad M. Zemse, Chin Wei Chiao, Gisele F. Bomfim, Rita C. Tostes, R Clinton Webb, Fernanda R. Giachini

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aims Interleukin-10 (IL-10) is a multi-functional cytokine with potent anti-inflammatory properties. We hypothesized that IL-10 limits increased RhoA/Rho-kinase signaling and vascular reactivity in arteries from angiotensin II (Ang II) hypertensive mice. Main methods Wild type (WT) and IL-10 knockout (-/-) mice were infused with Ang II (90 ng/min) for 14 days. Additionally, WT mice were infused with Ang II and simultaneously infused with exogenous IL-10 (0.5 ηg/min, 14 days). Aortic rings were mounted in a myograph and concentration-response curve to phenylephrine (PE) were evaluated. Key findings After Ang II infusion, blood pressure responses, but not maximal contraction to PE, was greater in IL-10-/- mice, compared to WT. Rho-kinase inhibition (Y-27632; 10 μM) resulted in a more evident reduction of PE-induced contraction in WT hypertensive mice, when compared to IL-10-/- hypertensive mice. IL-10 exogenous infusion prevented the blood pressure increase in Ang II-infused WT mice. The augmented PE-contraction observed in aorta from WT mice infused with Ang II was also prevented by exogenous infusion of IL-10. Additionally, Rho-kinase inhibition (Y-27632; 10 μM) abolished the differences in the contractile response to PE between these groups. Significance These results demonstrate that IL-10 counteracts both the pressoric activity of Ang II as well as vascular dysfunction associated with hypertension, partially, modulating the RhoA-Rho kinase pathway. Strategies to enhance IL-10 levels during hypertension may enhance the benefits provided by regular treatments.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalLife sciences
Volume145
DOIs
StatePublished - Jan 15 2016

Fingerprint

rho-Associated Kinases
Blood pressure
Angiotensin II
Interleukin-10
Blood Vessels
Blood Pressure
Phenylephrine
Hypertension
Knockout Mice
Aorta
Anti-Inflammatory Agents
Arteries
Cytokines

Keywords

  • Cytokine
  • Inflammation
  • Vascular dysfunction

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice. / Lima, Victor V.; Zemse, Saiprasad M.; Chiao, Chin Wei; Bomfim, Gisele F.; Tostes, Rita C.; Webb, R Clinton; Giachini, Fernanda R.

In: Life sciences, Vol. 145, 15.01.2016, p. 137-143.

Research output: Contribution to journalArticle

Lima, Victor V. ; Zemse, Saiprasad M. ; Chiao, Chin Wei ; Bomfim, Gisele F. ; Tostes, Rita C. ; Webb, R Clinton ; Giachini, Fernanda R. / Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice. In: Life sciences. 2016 ; Vol. 145. pp. 137-143.
@article{273409396483426db6bd8792323ab8cb,
title = "Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice",
abstract = "Aims Interleukin-10 (IL-10) is a multi-functional cytokine with potent anti-inflammatory properties. We hypothesized that IL-10 limits increased RhoA/Rho-kinase signaling and vascular reactivity in arteries from angiotensin II (Ang II) hypertensive mice. Main methods Wild type (WT) and IL-10 knockout (-/-) mice were infused with Ang II (90 ng/min) for 14 days. Additionally, WT mice were infused with Ang II and simultaneously infused with exogenous IL-10 (0.5 ηg/min, 14 days). Aortic rings were mounted in a myograph and concentration-response curve to phenylephrine (PE) were evaluated. Key findings After Ang II infusion, blood pressure responses, but not maximal contraction to PE, was greater in IL-10-/- mice, compared to WT. Rho-kinase inhibition (Y-27632; 10 μM) resulted in a more evident reduction of PE-induced contraction in WT hypertensive mice, when compared to IL-10-/- hypertensive mice. IL-10 exogenous infusion prevented the blood pressure increase in Ang II-infused WT mice. The augmented PE-contraction observed in aorta from WT mice infused with Ang II was also prevented by exogenous infusion of IL-10. Additionally, Rho-kinase inhibition (Y-27632; 10 μM) abolished the differences in the contractile response to PE between these groups. Significance These results demonstrate that IL-10 counteracts both the pressoric activity of Ang II as well as vascular dysfunction associated with hypertension, partially, modulating the RhoA-Rho kinase pathway. Strategies to enhance IL-10 levels during hypertension may enhance the benefits provided by regular treatments.",
keywords = "Cytokine, Inflammation, Vascular dysfunction",
author = "Lima, {Victor V.} and Zemse, {Saiprasad M.} and Chiao, {Chin Wei} and Bomfim, {Gisele F.} and Tostes, {Rita C.} and Webb, {R Clinton} and Giachini, {Fernanda R.}",
year = "2016",
month = "1",
day = "15",
doi = "10.1016/j.lfs.2015.12.009",
language = "English (US)",
volume = "145",
pages = "137--143",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice

AU - Lima, Victor V.

AU - Zemse, Saiprasad M.

AU - Chiao, Chin Wei

AU - Bomfim, Gisele F.

AU - Tostes, Rita C.

AU - Webb, R Clinton

AU - Giachini, Fernanda R.

PY - 2016/1/15

Y1 - 2016/1/15

N2 - Aims Interleukin-10 (IL-10) is a multi-functional cytokine with potent anti-inflammatory properties. We hypothesized that IL-10 limits increased RhoA/Rho-kinase signaling and vascular reactivity in arteries from angiotensin II (Ang II) hypertensive mice. Main methods Wild type (WT) and IL-10 knockout (-/-) mice were infused with Ang II (90 ng/min) for 14 days. Additionally, WT mice were infused with Ang II and simultaneously infused with exogenous IL-10 (0.5 ηg/min, 14 days). Aortic rings were mounted in a myograph and concentration-response curve to phenylephrine (PE) were evaluated. Key findings After Ang II infusion, blood pressure responses, but not maximal contraction to PE, was greater in IL-10-/- mice, compared to WT. Rho-kinase inhibition (Y-27632; 10 μM) resulted in a more evident reduction of PE-induced contraction in WT hypertensive mice, when compared to IL-10-/- hypertensive mice. IL-10 exogenous infusion prevented the blood pressure increase in Ang II-infused WT mice. The augmented PE-contraction observed in aorta from WT mice infused with Ang II was also prevented by exogenous infusion of IL-10. Additionally, Rho-kinase inhibition (Y-27632; 10 μM) abolished the differences in the contractile response to PE between these groups. Significance These results demonstrate that IL-10 counteracts both the pressoric activity of Ang II as well as vascular dysfunction associated with hypertension, partially, modulating the RhoA-Rho kinase pathway. Strategies to enhance IL-10 levels during hypertension may enhance the benefits provided by regular treatments.

AB - Aims Interleukin-10 (IL-10) is a multi-functional cytokine with potent anti-inflammatory properties. We hypothesized that IL-10 limits increased RhoA/Rho-kinase signaling and vascular reactivity in arteries from angiotensin II (Ang II) hypertensive mice. Main methods Wild type (WT) and IL-10 knockout (-/-) mice were infused with Ang II (90 ng/min) for 14 days. Additionally, WT mice were infused with Ang II and simultaneously infused with exogenous IL-10 (0.5 ηg/min, 14 days). Aortic rings were mounted in a myograph and concentration-response curve to phenylephrine (PE) were evaluated. Key findings After Ang II infusion, blood pressure responses, but not maximal contraction to PE, was greater in IL-10-/- mice, compared to WT. Rho-kinase inhibition (Y-27632; 10 μM) resulted in a more evident reduction of PE-induced contraction in WT hypertensive mice, when compared to IL-10-/- hypertensive mice. IL-10 exogenous infusion prevented the blood pressure increase in Ang II-infused WT mice. The augmented PE-contraction observed in aorta from WT mice infused with Ang II was also prevented by exogenous infusion of IL-10. Additionally, Rho-kinase inhibition (Y-27632; 10 μM) abolished the differences in the contractile response to PE between these groups. Significance These results demonstrate that IL-10 counteracts both the pressoric activity of Ang II as well as vascular dysfunction associated with hypertension, partially, modulating the RhoA-Rho kinase pathway. Strategies to enhance IL-10 levels during hypertension may enhance the benefits provided by regular treatments.

KW - Cytokine

KW - Inflammation

KW - Vascular dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84950341354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950341354&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2015.12.009

DO - 10.1016/j.lfs.2015.12.009

M3 - Article

C2 - 26682936

AN - SCOPUS:84950341354

VL - 145

SP - 137

EP - 143

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

ER -